Filtros : "Indexado na Base de Dados PubMed" "CHAVES, MARIA LUIZA MORAIS BARRETO DE" Removido: "FSP" Limpar

Filtros



Refine with date range


  • Source: Clinical Science. Unidade: ICB

    Subjects: ANGIOTENSINAS, CORAÇÃO, HIPERTIREOIDISMO, SISTEMA RENINA-ANGIOTENSINA, HORMÔNIOS TIREOIDIANOS, ANGIOTENSINA II, ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SENGER, Nathalia et al. Angiotensin-(1–7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway. Clinical Science, v. 132, n. 11, p. 1117-1133, 2018Tradução . . Disponível em: https://doi.org/10.1042/CS20171606. Acesso em: 29 jun. 2024.
    • APA

      Senger, N., Melo, M. B., Diniz, G. P., Santos, M. J. C. dos, Santos, R. A. S. dos, & Barreto-Chaves, M. L. M. (2018). Angiotensin-(1–7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway. Clinical Science, 132( 11), 1117-1133. doi:10.1042/CS20171606
    • NLM

      Senger N, Melo MB, Diniz GP, Santos MJC dos, Santos RAS dos, Barreto-Chaves MLM. Angiotensin-(1–7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway [Internet]. Clinical Science. 2018 ; 132( 11): 1117-1133.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1042/CS20171606
    • Vancouver

      Senger N, Melo MB, Diniz GP, Santos MJC dos, Santos RAS dos, Barreto-Chaves MLM. Angiotensin-(1–7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway [Internet]. Clinical Science. 2018 ; 132( 11): 1117-1133.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1042/CS20171606
  • Source: Journal of Cellular Physiology. Unidade: ICB

    Subjects: ANATOMIA, HIPERTIREOIDISMO, HORMÔNIOS TIREOIDIANOS, RNA DE TRANSFERÊNCIA, SISTEMA RENINA-ANGIOTENSINA, RATOS WISTAR, BLOQUEIO CARDÍACO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DINIZ, Gabriela Placoná et al. MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone. Journal of Cellular Physiology, v. 232, n. 12, p. 3360-3368, 2017Tradução . . Disponível em: https://doi.org/10.1002/jcp.25781. Acesso em: 29 jun. 2024.
    • APA

      Diniz, G. P., Lino, C. A., Moreno, C. R., Senger, N., & Barreto-Chaves, M. L. M. (2017). MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone. Journal of Cellular Physiology, 232( 12), 3360-3368. doi:10.1002/jcp.25781
    • NLM

      Diniz GP, Lino CA, Moreno CR, Senger N, Barreto-Chaves MLM. MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone [Internet]. Journal of Cellular Physiology. 2017 ; 232( 12): 3360-3368.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1002/jcp.25781
    • Vancouver

      Diniz GP, Lino CA, Moreno CR, Senger N, Barreto-Chaves MLM. MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone [Internet]. Journal of Cellular Physiology. 2017 ; 232( 12): 3360-3368.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1002/jcp.25781
  • Source: Journal of Molecular Medicine. Unidade: ICB

    Assunto: ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TAKANO, Ana Paula Cremasco et al. S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone. Journal of Molecular Medicine, v. 95, n. 6, p. 671-682, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00109-017-1511-y. Acesso em: 29 jun. 2024.
    • APA

      Takano, A. P. C., Munhoz, C. D., Moriscot, A. S., Gupta, S., & Barreto-Chaves, M. L. M. (2017). S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone. Journal of Molecular Medicine, 95( 6), 671-682. doi:10.1007/s00109-017-1511-y
    • NLM

      Takano APC, Munhoz CD, Moriscot AS, Gupta S, Barreto-Chaves MLM. S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone [Internet]. Journal of Molecular Medicine. 2017 ; 95( 6): 671-682.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/s00109-017-1511-y
    • Vancouver

      Takano APC, Munhoz CD, Moriscot AS, Gupta S, Barreto-Chaves MLM. S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone [Internet]. Journal of Molecular Medicine. 2017 ; 95( 6): 671-682.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/s00109-017-1511-y
  • Source: Clinical Science. Unidade: ICB

    Subjects: ANATOMIA, FISIOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DINIZ, Gabriela Placoná et al. Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy. Clinical Science, v. 131, n. 24, p. 2885-2900, 2017Tradução . . Disponível em: https://doi.org/10.1042/CS20171368. Acesso em: 29 jun. 2024.
    • APA

      Diniz, G. P., Huang, Z. -P., Liu, J., Chen, J., Ding, J., Fonseca, R. I., et al. (2017). Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy. Clinical Science, 131( 24), 2885-2900. doi:10.1042/CS20171368
    • NLM

      Diniz GP, Huang Z-P, Liu J, Chen J, Ding J, Fonseca RI, Barreto-Chaves MLM, Donato Junior J, Hu X, Wang D-Z. Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy [Internet]. Clinical Science. 2017 ; 131( 24): 2885-2900.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1042/CS20171368
    • Vancouver

      Diniz GP, Huang Z-P, Liu J, Chen J, Ding J, Fonseca RI, Barreto-Chaves MLM, Donato Junior J, Hu X, Wang D-Z. Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy [Internet]. Clinical Science. 2017 ; 131( 24): 2885-2900.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1042/CS20171368
  • Source: Therapeutic Advances in Cardiovascular Disease. Unidade: ICB

    Assunto: ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DINIZ, Gabriela Placoná et al. Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy. Therapeutic Advances in Cardiovascular Disease, v. 10, n. 4, p. 192-202, 2016Tradução . . Disponível em: https://doi.org/10.1177/1753944715623228. Acesso em: 29 jun. 2024.
    • APA

      Diniz, G. P., Senger, N., Carneiro-Ramos, M. S., Santos, R. A. S., & Barreto-Chaves, M. L. M. (2016). Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy. Therapeutic Advances in Cardiovascular Disease, 10( 4), 192-202. doi:10.1177/1753944715623228
    • NLM

      Diniz GP, Senger N, Carneiro-Ramos MS, Santos RAS, Barreto-Chaves MLM. Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy [Internet]. Therapeutic Advances in Cardiovascular Disease. 2016 ; 10( 4): 192-202.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1177/1753944715623228
    • Vancouver

      Diniz GP, Senger N, Carneiro-Ramos MS, Santos RAS, Barreto-Chaves MLM. Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy [Internet]. Therapeutic Advances in Cardiovascular Disease. 2016 ; 10( 4): 192-202.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1177/1753944715623228
  • Source: Basic Research in Cardiology. Unidade: ICB

    Subjects: ANATOMIA, HORMÔNIOS TIREOIDIANOS, SISTEMA RENINA-ANGIOTENSINA, ANGIOTENSINA II

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DINIZ, Gabriela Placoná et al. Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor. Basic Research in Cardiology, v. 110, n. 5, p. 1-11, 2015Tradução . . Disponível em: https://doi.org/10.1007/s00395-015-0504-7. Acesso em: 29 jun. 2024.
    • APA

      Diniz, G. P., Lino, C. A., Guedes, E. C., Moreira, L. do N., & Barreto-Chaves, M. L. M. (2015). Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor. Basic Research in Cardiology, 110( 5), 1-11. doi:10.1007/s00395-015-0504-7
    • NLM

      Diniz GP, Lino CA, Guedes EC, Moreira L do N, Barreto-Chaves MLM. Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor [Internet]. Basic Research in Cardiology. 2015 ; 110( 5): 1-11.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/s00395-015-0504-7
    • Vancouver

      Diniz GP, Lino CA, Guedes EC, Moreira L do N, Barreto-Chaves MLM. Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor [Internet]. Basic Research in Cardiology. 2015 ; 110( 5): 1-11.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/s00395-015-0504-7
  • Source: PLOS ONE. Unidades: ICB, FMRP

    Subjects: ANATOMIA, FARMACOLOGIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CERAVOLO, Graziela S. et al. An Interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies. PLOS ONE, v. 9, n. 11, 2014Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0111117. Acesso em: 29 jun. 2024.
    • APA

      Ceravolo, G. S., Montezano, A. C., Jordão, M. T., Akamine, E. H., Costa, T. J. da, Takano, A. P. C., et al. (2014). An Interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies. PLOS ONE, 9( 11). doi:10.1371/journal.pone.0111117
    • NLM

      Ceravolo GS, Montezano AC, Jordão MT, Akamine EH, Costa TJ da, Takano APC, Fernandes DC, Barreto-Chaves MLM, Laurindo FR, Tostes R de C, Fortes ZB, Chopard RP, Touyz RM, Carvalho MHC de. An Interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies [Internet]. PLOS ONE. 2014 ; 9( 11):[citado 2024 jun. 29 ] Available from: https://doi.org/10.1371/journal.pone.0111117
    • Vancouver

      Ceravolo GS, Montezano AC, Jordão MT, Akamine EH, Costa TJ da, Takano APC, Fernandes DC, Barreto-Chaves MLM, Laurindo FR, Tostes R de C, Fortes ZB, Chopard RP, Touyz RM, Carvalho MHC de. An Interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies [Internet]. PLOS ONE. 2014 ; 9( 11):[citado 2024 jun. 29 ] Available from: https://doi.org/10.1371/journal.pone.0111117
  • Source: Cardiovascular Drugs and Therapy. Unidade: ICB

    Assunto: ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TAVARES, Felix Meira et al. Angiotensin II Type 2 Receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion. Cardiovascular Drugs and Therapy, v. 27, n. 5, p. 393-402, 2013Tradução . . Disponível em: https://doi.org/10.1007/s10557-013-6473-x. Acesso em: 29 jun. 2024.
    • APA

      Tavares, F. M., Silva, I. B. da, Gomes, D. A., & Barreto-Chaves, M. L. M. (2013). Angiotensin II Type 2 Receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion. Cardiovascular Drugs and Therapy, 27( 5), 393-402. doi:10.1007/s10557-013-6473-x
    • NLM

      Tavares FM, Silva IB da, Gomes DA, Barreto-Chaves MLM. Angiotensin II Type 2 Receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion [Internet]. Cardiovascular Drugs and Therapy. 2013 ; 27( 5): 393-402.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/s10557-013-6473-x
    • Vancouver

      Tavares FM, Silva IB da, Gomes DA, Barreto-Chaves MLM. Angiotensin II Type 2 Receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion [Internet]. Cardiovascular Drugs and Therapy. 2013 ; 27( 5): 393-402.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/s10557-013-6473-x
  • Source: Molecular and Cellular Endocrinology. Unidade: ICB

    Assunto: ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TAKANO, Ana Paula Cremasco e DINIZ, Gabriela Placoná e BARRETO-CHAVES, Maria Luiza Morais. AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth. Molecular and Cellular Endocrinology, v. 376, n. 1-2, p. 43-50, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.mce.2013.05.024. Acesso em: 29 jun. 2024.
    • APA

      Takano, A. P. C., Diniz, G. P., & Barreto-Chaves, M. L. M. (2013). AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth. Molecular and Cellular Endocrinology, 376( 1-2), 43-50. doi:10.1016/j.mce.2013.05.024
    • NLM

      Takano APC, Diniz GP, Barreto-Chaves MLM. AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth [Internet]. Molecular and Cellular Endocrinology. 2013 ; 376( 1-2): 43-50.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.mce.2013.05.024
    • Vancouver

      Takano APC, Diniz GP, Barreto-Chaves MLM. AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth [Internet]. Molecular and Cellular Endocrinology. 2013 ; 376( 1-2): 43-50.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.mce.2013.05.024
  • Source: Molecular Endocrinology. Unidade: ICB

    Assunto: ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROZANSKI, Andrei et al. M-Protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats. Molecular Endocrinology, v. 27, n. 12, p. 2055-2065, 2013Tradução . . Disponível em: https://doi.org/10.1210/me.2013-1018. Acesso em: 29 jun. 2024.
    • APA

      Rozanski, A., Takano, A. P. C., Kato, P. N., Soares, A. G., Lellis-Santos, C., Campos, J. C., et al. (2013). M-Protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats. Molecular Endocrinology, 27( 12), 2055-2065. doi:10.1210/me.2013-1018
    • NLM

      Rozanski A, Takano APC, Kato PN, Soares AG, Lellis-Santos C, Campos JC, Ferreira JCB, Barreto-Chaves MLM, Moriscot AS. M-Protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats [Internet]. Molecular Endocrinology. 2013 ; 27( 12): 2055-2065.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1210/me.2013-1018
    • Vancouver

      Rozanski A, Takano APC, Kato PN, Soares AG, Lellis-Santos C, Campos JC, Ferreira JCB, Barreto-Chaves MLM, Moriscot AS. M-Protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats [Internet]. Molecular Endocrinology. 2013 ; 27( 12): 2055-2065.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1210/me.2013-1018
  • Source: Molecular and Cellular Endocrinology. Unidade: ICB

    Assunto: ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DINIZ, Gabriela Placoná e TAKANO, Ana Paula Cremasco e BARRETO-CHAVES, Maria Luiza Morais. miRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy – Role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation. Molecular and Cellular Endocrinology, v. 374, n. 1-2, p. 117-124, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.mce.2013.04.010. Acesso em: 29 jun. 2024.
    • APA

      Diniz, G. P., Takano, A. P. C., & Barreto-Chaves, M. L. M. (2013). miRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy – Role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation. Molecular and Cellular Endocrinology, 374( 1-2), 117-124. doi:10.1016/j.mce.2013.04.010
    • NLM

      Diniz GP, Takano APC, Barreto-Chaves MLM. miRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy – Role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation [Internet]. Molecular and Cellular Endocrinology. 2013 ; 374( 1-2): 117-124.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.mce.2013.04.010
    • Vancouver

      Diniz GP, Takano APC, Barreto-Chaves MLM. miRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy – Role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation [Internet]. Molecular and Cellular Endocrinology. 2013 ; 374( 1-2): 117-124.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.mce.2013.04.010
  • Source: PLOS ONE. Unidades: ICB, FMRP

    Subjects: ANATOMIA, FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARRILLO-SEPÚLVEDA, Maria Alícia et al. Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism. PLOS ONE, v. 8, n. 4, p. 1-9, 2013Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0061982. Acesso em: 29 jun. 2024.
    • APA

      Carrillo-Sepúlveda, M. A., Ceravolo, G. S., Furstenau, C. R., Monteiro, P. de S., Bruno-Fortes, Z., Carvalho, M. H. C. de, et al. (2013). Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism. PLOS ONE, 8( 4), 1-9. doi:10.1371/journal.pone.0061982
    • NLM

      Carrillo-Sepúlveda MA, Ceravolo GS, Furstenau CR, Monteiro P de S, Bruno-Fortes Z, Carvalho MHC de, Laurindo FR, Tostes R de C, Webb RC, Barreto-Chaves MLM. Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism [Internet]. PLOS ONE. 2013 ;8( 4): 1-9.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1371/journal.pone.0061982
    • Vancouver

      Carrillo-Sepúlveda MA, Ceravolo GS, Furstenau CR, Monteiro P de S, Bruno-Fortes Z, Carvalho MHC de, Laurindo FR, Tostes R de C, Webb RC, Barreto-Chaves MLM. Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism [Internet]. PLOS ONE. 2013 ;8( 4): 1-9.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1371/journal.pone.0061982
  • Source: Journal of Molecular Endocrinology. Unidade: ICB

    Subjects: ANATOMIA, FISIOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DINIZ, Gabriela Placoná et al. New insight into the mechanisms associated with the rapid effect of T3 on AT1R expression. Journal of Molecular Endocrinology, v. 49, n. 1, p. 11-20, 2012Tradução . . Disponível em: https://doi.org/10.1530/JME-11-0141. Acesso em: 29 jun. 2024.
    • APA

      Diniz, G. P., Takano, A. P. C., Brunetto-Ract, E. L., Silva, F. G. da, Nunes, M. T., & Barreto-Chaves, M. L. M. (2012). New insight into the mechanisms associated with the rapid effect of T3 on AT1R expression. Journal of Molecular Endocrinology, 49( 1), 11-20. doi:10.1530/JME-11-0141
    • NLM

      Diniz GP, Takano APC, Brunetto-Ract EL, Silva FG da, Nunes MT, Barreto-Chaves MLM. New insight into the mechanisms associated with the rapid effect of T3 on AT1R expression [Internet]. Journal of Molecular Endocrinology. 2012 ; 49( 1): 11-20.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1530/JME-11-0141
    • Vancouver

      Diniz GP, Takano APC, Brunetto-Ract EL, Silva FG da, Nunes MT, Barreto-Chaves MLM. New insight into the mechanisms associated with the rapid effect of T3 on AT1R expression [Internet]. Journal of Molecular Endocrinology. 2012 ; 49( 1): 11-20.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1530/JME-11-0141
  • Source: Life Sciences. Unidade: ICB

    Assunto: ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      COTOMACCI, Guilherme et al. Thyroid hormones are involved in 5′-nucleotidase modulation in soluble fraction of cardiac tissue. Life Sciences, v. 91, n. 3-4, p. 137-142, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2012.06.023. Acesso em: 29 jun. 2024.
    • APA

      Cotomacci, G., Sarkis, J. J. F., Fürstenau, C. R., & Barreto-Chaves, M. L. M. (2012). Thyroid hormones are involved in 5′-nucleotidase modulation in soluble fraction of cardiac tissue. Life Sciences, 91( 3-4), 137-142. doi:10.1016/j.lfs.2012.06.023
    • NLM

      Cotomacci G, Sarkis JJF, Fürstenau CR, Barreto-Chaves MLM. Thyroid hormones are involved in 5′-nucleotidase modulation in soluble fraction of cardiac tissue [Internet]. Life Sciences. 2012 ; 91( 3-4): 137-142.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.lfs.2012.06.023
    • Vancouver

      Cotomacci G, Sarkis JJF, Fürstenau CR, Barreto-Chaves MLM. Thyroid hormones are involved in 5′-nucleotidase modulation in soluble fraction of cardiac tissue [Internet]. Life Sciences. 2012 ; 91( 3-4): 137-142.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.lfs.2012.06.023
  • Source: Molecular and Cellular Endocrinology. Unidade: ICB

    Assunto: ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ARAUJO, A. S. R. et al. Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin–angiotensin system. Molecular and Cellular Endocrinology, v. 333, n. 1, p. 78-84, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.mce.2010.12.018. Acesso em: 29 jun. 2024.
    • APA

      Araujo, A. S. R., Diniz, G. P., Seibel, F. E. R., Branchini, G., Ribeiro, M. F. M., Brum, I. S., et al. (2011). Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin–angiotensin system. Molecular and Cellular Endocrinology, 333( 1), 78-84. doi:10.1016/j.mce.2010.12.018
    • NLM

      Araujo ASR, Diniz GP, Seibel FER, Branchini G, Ribeiro MFM, Brum IS, Khaper N, Barreto-Chaves MLM, Belló-Klein A. Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin–angiotensin system [Internet]. Molecular and Cellular Endocrinology. 2011 ; 333( 1): 78-84.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.mce.2010.12.018
    • Vancouver

      Araujo ASR, Diniz GP, Seibel FER, Branchini G, Ribeiro MFM, Brum IS, Khaper N, Barreto-Chaves MLM, Belló-Klein A. Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin–angiotensin system [Internet]. Molecular and Cellular Endocrinology. 2011 ; 333( 1): 78-84.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.mce.2010.12.018
  • Source: Vascular Pharmacology. Unidade: ICB

    Assunto: ANATOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BARRETO-CHAVES, Maria Luiza Morais et al. The crosstalk between thyroid hormones and the Renin–Angiotensin System. Vascular Pharmacology, v. 52, n. 3-4, p. 166-170, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.vph.2009.10.009. Acesso em: 29 jun. 2024.
    • APA

      Barreto-Chaves, M. L. M., Carrillo-Sepúlveda, M. A., Carneiro-Ramos, M. S., Gomes, D. A., & Diniz, G. P. (2010). The crosstalk between thyroid hormones and the Renin–Angiotensin System. Vascular Pharmacology, 52( 3-4), 166-170. doi:10.1016/j.vph.2009.10.009
    • NLM

      Barreto-Chaves MLM, Carrillo-Sepúlveda MA, Carneiro-Ramos MS, Gomes DA, Diniz GP. The crosstalk between thyroid hormones and the Renin–Angiotensin System [Internet]. Vascular Pharmacology. 2010 ; 52( 3-4): 166-170.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.vph.2009.10.009
    • Vancouver

      Barreto-Chaves MLM, Carrillo-Sepúlveda MA, Carneiro-Ramos MS, Gomes DA, Diniz GP. The crosstalk between thyroid hormones and the Renin–Angiotensin System [Internet]. Vascular Pharmacology. 2010 ; 52( 3-4): 166-170.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.vph.2009.10.009

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024